These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20144452)

  • 1. A crescent-shaped spindle for improved dissolution testing.
    Qureshi SA
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):55-65. PubMed ID: 20144452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved drug dissolution and product characterization using a crescent-shaped spindle.
    Qureshi SA
    J Pharm Pharmacol; 2004 Sep; 56(9):1135-41. PubMed ID: 15324482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choice of rotation speed (rpm) for bio-relevant drug dissolution testing using a crescent-shaped spindle.
    Qureshi SA
    Eur J Pharm Sci; 2004 Nov; 23(3):271-5. PubMed ID: 15489128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory aspects of modified release dosage forms: special cases of dissolution testing using the flow-through system.
    Möller H; Wirbitzki E
    Boll Chim Farm; 1993 Apr; 132(4):105-15. PubMed ID: 8333916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of a new device (spindle) for improved characterization of drug release (dissolution) of pharmaceutical products.
    Qureshi SA; Shabnam J
    Eur J Pharm Sci; 2003 Jul; 19(4):291-7. PubMed ID: 12885394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Validation of dissolution testing: evaluation of vibration levels of dissolution apparatuses].
    Kaniwa N; Katori N; Aoyagi N; Kojima S; Ishigame N; Seta Y; Shinba T; Fujiwara K; Nakai T; Oda Y
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):189-91. PubMed ID: 10097538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probability of passing dissolution acceptance criteria for an immediate release tablet.
    Dumont ML; Berry MR; Nickerson B
    J Pharm Biomed Anal; 2007 May; 44(1):79-84. PubMed ID: 17379465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses.
    Garbacz G; Golke B; Wedemeyer RS; Axell M; Söderlind E; Abrahamsson B; Weitschies W
    Eur J Pharm Sci; 2009 Sep; 38(2):147-55. PubMed ID: 19591927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution test development for complex veterinary dosage forms: oral boluses.
    Fahmy R; Marnane B; Bensley D; Hollenbeck RG
    AAPS PharmSci; 2002; 4(4):E35. PubMed ID: 12646007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.
    Breier AR; Paim CS; Steppe M; Schapoval EE
    J Pharm Pharm Sci; 2005 Aug; 8(2):289-98. PubMed ID: 16124939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence.
    Miller DA; Gamba M; Sauer D; Purvis TP; Clemens NT; Williams RO
    Int J Pharm; 2007 Feb; 330(1-2):61-72. PubMed ID: 17034967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro dissolution methods for controlled release parenterals and their applicability to drug-eluting stent testing.
    Seidlitz A; Weitschies W
    J Pharm Pharmacol; 2012 Jul; 64(7):969-85. PubMed ID: 22686343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An optical method for continuous monitoring of the dissolution rate of pharmaceutical powders.
    Laitinen R; Lahtinen J; Silfsten P; Vartiainen E; Jarho P; Ketolainen J
    J Pharm Biomed Anal; 2010 Jun; 52(2):181-9. PubMed ID: 20116958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of hydrodynamics in the basket dissolution apparatus using computational fluid dynamics--dissolution rate implications.
    D'Arcy DM; Corrigan OI; Healy AM
    Eur J Pharm Sci; 2006 Feb; 27(2-3):259-67. PubMed ID: 16314078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a dissolution test for a once-a-day combination tablet of immediate-release cetirizine dihydrochloride and extended-release pseudoephedrine hydrochloride.
    Likar MD; Mansour HL; Harwood JW
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):543-51. PubMed ID: 15975755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
    Blagden N; de Matas M; Gavan PT; York P
    Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory aspects of drug dissolution from a European perspective.
    Graffner C
    Eur J Pharm Sci; 2006 Nov; 29(3-4):288-93. PubMed ID: 16950606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The random vibration effects on dissolution testing with USP apparatus 2.
    Gao Z; Moore TW; Buhse LF; Doub WH
    J Pharm Sci; 2009 Jan; 98(1):297-306. PubMed ID: 18399543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two dissolution apparatuses: rotating basket versus rotating flask.
    Koch HP; Alcorn G; Ritschel WA
    Pharmazie; 1983 Apr; 38(4):233-5. PubMed ID: 6867085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.